Wise raises €6.5M Series B round

The company intended to use the funds to market its Cortical Electrodes for intraoperative monitoring and to conclude the development of its percutaneously-implantable paddle lead for Spinal Cord Stimulation.

Source: https://www.htgf.de/en/wise-srl-raises-eur-6-5-million-for-clinical-validation-of-novel-neuroelectrodes-for-brain-monitoring-and-spinal-cord-stimulation/